Clinical Trial Update: A Trial of Cardiac Injections of iMP Cells During CABG Surgery [Phase 2]

View source ↗

Summary

Phase 2 trial investigating cardiac injections of iMP cells during CABG surgery for myocardial fibrosis is in unknown status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Fibrosis

Drugs mentioned

• iMP cells

Snippet

Sponsor: Cell Therapy Ltd. | Conditions: Myocardial Fibrosis | Phase 2 | Status: UNKNOWN